IperionX Limited
TAOFF
$2.15
-$0.13-5.70%
| Weiss Ratings | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Price History | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -39.78% | |||
| 60-Day Total Return | -15.69% | |||
| 90-Day Total Return | -12.59% | |||
| Year to Date Total Return | -39.78% | |||
| 1-Year Total Return | 65.38% | |||
| 2-Year Total Return | 264.41% | |||
| 3-Year Total Return | 168.75% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -41.42% | |||
| 52-Week Low % Change | 95.45% | |||
| Price | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.67 | |||
| 52-Week Low Price | $1.10 | |||
| 52-Week Low Price (Date) | Mar 20, 2024 | |||
| 52-Week High Price (Date) | Dec 30, 2024 | |||
| Valuation | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 635.76M | |||
| Enterprise Value | 561.39M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.11 | |||
| Earnings Per Share Growth | 15.03% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 6.43 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.15 | |||
| Enterprise Value/EBITDA (TTM) | -21.81 | |||
| Enterprise Value/EBIT | -21.51 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 270.61M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 980 237 8900 | |||
| Address | 129 West Trade Street Charlotte, NC 28202 | |||
| Website | iperionx.com | |||
| Country | United States | |||
| Year Founded | 2017 | |||
| Profitability | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -27.56% | |||
| Return on Equity | -- | |||
| Income Statement | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -32.59M | |||
| EBIT (TTM) | -33.04M | |||
| Net Income (TTM) | -27.59M | |||
| Net Income Avl. to Common (TTM) | -27.59M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -54.71% | |||
| EPS Diluted (TTM) | -0.11 | |||
| EPS Diluted Growth (Q YOY) | -20.00% | |||
| Balance Sheet | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 77.13M | |||
| Cash Per Share (Q) | $0.29 | |||
| Total Current Assets (Q) | 78.78M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 105.54M | |||
| Current Ratio (Q) | 11.803 | |||
| Book Value Per Share (Q) | $0.33 | |||
| Total Assets (Q) | 115.83M | |||
| Total Current Liabilities (Q) | 6.67M | |||
| Total Debt (Q) | 4.19M | |||
| Total Liabilities (Q) | 10.29M | |||
| Total Common Equity (Q) | 105.54M | |||
| Cash Flow | TAOFF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -12.66M | |||
| Cash from Financing (TTM) | 96.57M | |||
| Net Change in Cash (TTM) | 59.80M | |||
| Levered Free Cash Flow (TTM) | -15.48M | |||
| Cash from Operations (TTM) | -22.38M | |||
